-
Trader’s Watch List: Applied Materials (NASDAQ:AMAT), Galena Biopharma Inc (NASDAQ:GALE), Inphi Corporation (NYSE:IPHI), United States Cellular Corporation (NYSE:USM), Sony Corp (ADR) (NYSE:SNE)
On Thursday shares of Applied Materials, Inc. (NASDAQ:AMAT) closed at $19.86. Company’s sales growth for last 5 years was 12.60% and EPS growth for next 5 years is recorded as 13.00%. Applied Materials, Inc. (NASDAQ: AMAT) released its fiscal second-quarter financial results on Thursday after the markets closed. The company had $0.29 in earnings per…
-
Stocks in News: Bristol-Myers Squibb Company (NYSE:BMY), Host Hotels & Resorts (NYSE:HST), Galena Biopharma Inc (NASDAQ:GALE), CSX Corp. (NYSE:CSX)
On 15 April, Bristol-Myers Squibb Company (NYSE:BMY) shares moved down -0.94% and was closed at $63.43. BMY EPS growth in last 5 year was -5.90%. Bristol-Myers Squibb Company (NYSE:BMY) year to date (YTD) performance is 8.08%. Bristol-Myers Squibb Company (NYSE:BMY) said that, it will announce results for the first quarter of 2015 on Tuesday, April…
-
Investors Alert: Spar Group Inc. (NASDAQ:SGRP), Cliffs Natural Resources Inc. (NYSE:CLF), Galena Biopharma Inc (NASDAQ:GALE), FireEye (NASDAQ:FEYE), FuelCell Energy Inc. (NASDAQ:FCEL)
On Wednesday shares of Spar Group Inc. (NASDAQ:SGRP) closed at $1.27. Company’s sales growth for last 5 years was 10.00%.Spar Group Inc. (NASDAQ:SGRP) announced the financial results for the year and fourth quarter ending December 31, 2014. Revenue for the 2014 year and fourth quarter totaled $122 million and $32.1 million, an increase of 9%…
-
Hot Stock List: Fastenal Company (NASDAQ:FAST), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Village Super Market Inc. (NASDAQ:VLGEA), Mad Catz Interactive (NYSEMKT:MCZ), Galena Biopharma (NASDAQ:GALE)
On Tuesday shares of Fastenal Company (NASDAQ:FAST) closed at $41.79. Company’s sales growth for last 5 years was 14.10% and EPS growth for next 5 years is recorded as 14.85%. Fastenal Company (NASDAQ:FAST) reported Tuesday profit for the first quarter that grew 14 percent from last year, reflecting improved operating margins and net sales growth.…
-
Top News: Clean Energy Fuels Corp. (NASDAQ:CLNE), Galena Biopharma Inc (NASDAQ:GALE), L Brands (NYSE:LB), Golden Minerals Company (NYSEMKT:AUMN), DineEquity (NYSE:DIN)
On Tuesday shares of Clean Energy Fuels Corp. (NASDAQ:CLNE) closed at $6.55. Company’s sales growth for last 5 years was 26.70% and EPS growth for next 5 years is recorded as 25.00%. Clean Energy Fuels Corp. (NASDAQ:CLNE) announced fueling has begun at two new compressed natural gas (CNG) fueling station in Southern California as well…
-
Top Wall Street Stories: SunEdison (NYSE:SUNE), Applied Materials (NASDAQ:AMAT), Ruby Tuesday (NYSE:RT), HNI Corp. (NYSE:HNI), Galena Biopharma Inc (NASDAQ:GALE)
On Monday shares of SunEdison, Inc. (NYSE:SUNE) closed at $26.45. Company’s sales growth for last 5 years was 16.40% and EPS growth for next 5 years is recorded as 1.58% SunEdison, Inc. (NYSE:SUNE) announced that it has signed agreements to construct and install three new utility-scalesolar power plants in southern Utah with a total capacity…
-
Hot News: Diversicare Healthcare Services Inc. (NASDAQ:DVCR), Galena Biopharma Inc (NASDAQ:GALE), Merck & Co. Inc. (NYSE:MRK), Peabody Energy (NYSE:BTU), CTS Corporation (NYSE:CTS)
On Thursday shares of Diversicare Healthcare Services Inc. (NASDAQ:DVCR) closed at $15.65. Company’s sales growth for last 5 years was 4.40% Diversicare Healthcare Services Inc. (NASDAQ:DVCR) was upgraded by analysts at TheStreet from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday. On Thursday shares of…
-
Top Wall Street Stories: AbbVie Inc. (NYSE:ABBV), Parker Drilling Co. (NYSE:PKD), Galena Biopharma Inc (NASDAQ:GALE), ManpowerGroup Inc. (NYSE:MAN), HMN Financial Inc. (NASDAQ:HMNF)
On Tuesday shares of AbbVie Inc. (NYSE:ABBV) closed at $58.42. Company’s sales growth for last 5 years was 7.00% and EPS growth for next 5 years is recorded as 15.73%. AbbVie Inc. (NYSE:ABBV) announced that 29 abstracts from its ongoing hepatitis C clinical development program have been accepted for presentation during The International Liver CongressTM…